$79.5 Million is the total value of SABBY MANAGEMENT, LLC's 88 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 57.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | BIOGEN INCcall | $9,589,000 | -82.4% | 410 | -82.2% | 12.06% | -53.9% | |
| ODT | Sell | ODONATE THERAPEUTICS INC | $4,884,000 | -5.5% | 133,105 | -43.1% | 6.14% | +147.3% |
| Sell | CORMEDIX INCput | $2,572,000 | -64.9% | 4,633 | -40.2% | 3.23% | -8.1% | |
| Sell | WAVE LIFE SCIENCES LTDcall | $1,440,000 | -39.2% | 552 | -9.5% | 1.81% | +59.0% | |
| PAVMZ | Sell | PAVMED INC*w | $1,374,000 | -3.6% | 3,270,329 | -10.8% | 1.73% | +152.3% |
| ORMP | Sell | ORAMED PHARMACEUTICALS INC | $1,273,000 | -48.7% | 354,713 | -48.0% | 1.60% | +34.3% |
| SOLO | Sell | ELECTRAMECCANICA VEHS CORP | $1,132,000 | -39.7% | 452,796 | -14.1% | 1.42% | +57.8% |
| BCLI | Sell | BRAINSTORM CELL THERAPEUTICS INC | $625,000 | -80.7% | 158,152 | -78.8% | 0.79% | -49.4% |
| Sell | AMARIN CORPORATION PLCcall | $401,000 | -86.9% | 207 | -86.0% | 0.50% | -65.9% | |
| Sell | INPIXON | $378,000 | -33.0% | 596,204 | -13.8% | 0.48% | +75.3% | |
| Sell | SPDR S&P 500 ETFput | $315,000 | -99.4% | 920 | -48.2% | 0.40% | -98.4% | |
| VBLT | Sell | VASCULAR BIOGENICS LTD | $311,000 | -37.6% | 239,188 | -27.0% | 0.39% | +63.6% |
| ABILF | Sell | ABILITY INC | $277,000 | -59.0% | 301,137 | -23.6% | 0.35% | +7.1% |
| CODX | Sell | CO DIAGNOSTICS INC | $225,000 | -72.6% | 279,595 | -63.8% | 0.28% | -28.2% |
| EYEN | Sell | EYENOVIA INC | $213,000 | -45.7% | 49,500 | -24.4% | 0.27% | +42.6% |
| OPGN | Sell | OPGEN INC | $204,000 | -63.7% | 519,341 | -44.1% | 0.26% | -5.2% |
| Sell | VIKING THERAPEUTICS INCcall | $166,000 | -32.0% | 200 | -18.4% | 0.21% | +78.6% | |
| ISR | Sell | ISORAY INC | $152,000 | -67.5% | 370,612 | -71.0% | 0.19% | -14.7% |
| UMRX | Sell | UNUM THERAPEUTICS INC | $133,000 | -85.3% | 50,922 | -75.3% | 0.17% | -61.6% |
| APDNW | Sell | APPLIED DNA SCIENCES INC*w | $86,000 | +2050.0% | 21,504 | -88.8% | 0.11% | +5300.0% |
| Sell | ALTIMMUNE INCput | $85,000 | -76.9% | 233 | -81.6% | 0.11% | -39.5% | |
| SGLBW | Sell | SIGMA LABS INC*w | $21,000 | -63.2% | 65,033 | -26.5% | 0.03% | -3.7% |
| AKAOQ | Sell | ACHAOGEN INC | $3,000 | -98.1% | 134,192 | -61.5% | 0.00% | -94.7% |
| FCEL | Sell | FUELCELL ENERGY INC | $3,000 | -94.9% | 17,640 | -92.7% | 0.00% | -85.7% |
| BNTCW | Sell | BENITEC BIOPHARMA LTD*w | $1,000 | -83.3% | 56,949 | -1.7% | 0.00% | -66.7% |
| NSPRZ | Exit | INSPIREMD INC*w | $0 | – | -1,067,324 | -100.0% | 0.00% | – |
| PHIOW | Exit | PHIO PHARMACEUTICALS CORP*w | $0 | – | -194,959 | -100.0% | -0.00% | – |
| Exit | ACHAOGEN INCput | $0 | – | -136 | -100.0% | -0.00% | – | |
| Exit | NOVAVAX INCcall | $0 | – | -153 | -100.0% | -0.00% | – | |
| Exit | FUELCELL ENERGY INCput | $0 | – | -456 | -100.0% | -0.01% | – | |
| BLIN | Exit | BRIDGELINE DIGITAL INC | $0 | – | -100,000 | -100.0% | -0.01% | – |
| BLRX | Exit | BIOLINE RX LTDads | $0 | – | -36,999 | -100.0% | -0.01% | – |
| Exit | PLURISTEM THERAPEUTICS INCput | $0 | – | -239 | -100.0% | -0.01% | – | |
| Exit | PROTEOSTASIS THERAPEUTICS INCcall | $0 | – | -220 | -100.0% | -0.01% | – | |
| PTI | Exit | PROTEOSTASIS THERAPEUTICS INC | $0 | – | -30,900 | -100.0% | -0.02% | – |
| MKGI | Exit | MONAKER GROUP INC | $0 | – | -35,970 | -100.0% | -0.04% | – |
| Exit | NOVAN INC | $0 | – | -86,225 | -100.0% | -0.04% | – | |
| CUR | Exit | NEURALSTEM INC | $0 | – | -238,813 | -100.0% | -0.05% | – |
| HMTV | Exit | HEMISPHERX BIOPHARMA INC | $0 | – | -708,417 | -100.0% | -0.05% | – |
| KPTI | Exit | KARYOPHARM THERAPEUTICS INC | $0 | – | -25,000 | -100.0% | -0.07% | – |
| CRMD | Exit | CORMEDIX INC | $0 | – | -18,118 | -100.0% | -0.08% | – |
| PYDS | Exit | PAYMENT DATA SYS INC | $0 | – | -73,773 | -100.0% | -0.09% | – |
| Exit | REWALK ROBOTICS LTD | $0 | – | -914,857 | -100.0% | -0.10% | – | |
| BLPH | Exit | BELLEROPHON THERAPEUTICS INC | $0 | – | -308,912 | -100.0% | -0.10% | – |
| Exit | KARYOPHARM THERAPEUTICS INCcall | $0 | – | -359 | -100.0% | -0.10% | – | |
| HSGX | Exit | HISTOGENICS CORP | $0 | – | -1,900,100 | -100.0% | -0.11% | – |
| DMPI | Exit | DELMAR PHARMACEUTICALS INC | $0 | – | -496,502 | -100.0% | -0.12% | – |
| VTVT | Exit | VTV THERAPEUTICS INCcl a | $0 | – | -223,172 | -100.0% | -0.18% | – |
| Exit | MANNKIND CORPput | $0 | – | -2,018 | -100.0% | -0.19% | – | |
| TRNX | Exit | TARONIS TECHNOLOGIES INC | $0 | – | -721,600 | -100.0% | -0.22% | – |
| Exit | NOVAVAX INCput | $0 | – | -8,600 | -100.0% | -0.23% | – | |
| NVAX | Exit | NOVAVAX INC | $0 | – | -860,000 | -100.0% | -0.23% | – |
| AQB | Exit | AQUABOUNTY TECHNOLOGIES INC | $0 | – | -256,030 | -100.0% | -0.27% | – |
| FGEN | Exit | FIBROGEN INC | $0 | – | -13,195 | -100.0% | -0.34% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -7,000 | -100.0% | -0.80% | – |
| Exit | FIBROGEN INCcall | $0 | – | -336 | -100.0% | -0.88% | – | |
| LOOP | Exit | LOOP INDUSTRIES INC | $0 | – | -248,436 | -100.0% | -0.94% | – |
| Exit | BIOGEN INCput | $0 | – | -148 | -100.0% | -1.68% | – | |
| Exit | FIBROGEN INCput | $0 | – | -1,095 | -100.0% | -2.86% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.